RecruitingNot ApplicableNCT04449445

Perioperative Nutritional Optimization in Head and Neck Cancer Patients


Sponsor

University of Illinois at Chicago

Enrollment

300 participants

Start Date

May 10, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators hypothesize that nutritional supplementation with Nestle Impact Advanced Recovery (AR) will decrease the rate of wound complications after surgery


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an intensive nutritional support program before and after surgery improves recovery and reduces complications in patients with head and neck cancer. **You may be eligible if...** - You are 18 or older - You have been diagnosed with head and neck cancer and are scheduled for surgery - You are able to eat by mouth or via a feeding tube **You may NOT be eligible if...** - You have cancer that has spread to other parts of the body - You cannot eat or receive nutrition by mouth or feeding tube - You have galactosemia (a rare inability to process a type of sugar found in some nutrition supplements) - You have already started another nutritional supplement study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTIsocaloric and iso-nitrogenous standard enteral tube feeds

Dietary supplement

DIETARY_SUPPLEMENTNestle IMPACT AR

Dietary supplement


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04449445


Related Trials